Vox Examines PEPFAR’s History, Impact, Reauthorization

Vox: Trump signed a good law this week. Yes, really.
“On Tuesday, something odd happened in Washington: A bill became a law. It passed by unanimous consent in the Senate and voice vote in the House (typically taken when a measure faces no significant opposition), and was signed by President Donald Trump. … The bill reauthorized PEPFAR — the President’s Emergency Plan for AIDS Relief — through 2023. PEPFAR provides billions in annual funding and technical support for antiretroviral treatment, HIV-preventing male circumcisions, and other efforts to treat and prevent HIV. … Shockingly, PEPFAR is a major government program that is mostly uncontroversial. … ‘Bipartisanship is not dead,’ Jennifer Kates, the vice president and director for Global Health and HIV Policy at the Kaiser Family Foundation, told me…” (Matthews, 12/12).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.